Outcome for children <4 years of age with malignant central nervous system tumors treated with high-dose chemotherapy and autologous stem cell rescue

Pediatric Blood and Cancer

Volumn 48, Issue 3, 2007, Pages 278-284

  Thorarinsdottir, Halldora K ^a   Rood, Brian ^a,b,c   Kamani, Naynesh ^a,b,c   Lafond, Debbie ^a   Perez Albuerne, Evelio ^a   Loechelt, Brett ^a   Packer, Roger J ^a   MacDonald, Tobey J ^a,b,c  

^a CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^b CHILDREN S RESEARCH INSTITUTE   (United States)

^c GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

Autologous stem cell rescue; High dose chemotherapy; Malignant CNS tumors; Pediatric oncology; Peripheral blood stem cell infusion

Indexed keywords

BUSULFAN; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; ETOPOSIDE; METHOTREXATE; THIOTEPA; VINCRISTINE;

ADD ON THERAPY; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; BACTEREMIA; BONE MARROW SUPPRESSION; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANDIDIASIS; CENTRAL NERVOUS SYSTEM TUMOR; CLINICAL ARTICLE; COMBINATION CHEMOTHERAPY; DISEASE FREE SURVIVAL; DRUG DOSE REDUCTION; DRUG MEGADOSE; ELECTROLYTE DISTURBANCE; EPENDYMOMA; FEMALE; FEVER; GLIOBLASTOMA; HEARING LOSS; HEMATOCHEZIA; HUMAN; INFANT; LUNG HEMORRHAGE; MALE; MEDULLOBLASTOMA; MULTIPLE CYCLE TREATMENT; NEUROECTODERM TUMOR; NEUTROPENIA; OTOTOXICITY; OVERALL SURVIVAL; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; RASH;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRAIN NEOPLASMS; CARBOPLATIN; CHILD, PRESCHOOL; CISPLATIN; COGNITION DISORDERS; CRANIAL IRRADIATION; CYCLOPHOSPHAMIDE; DEVELOPMENTAL DISABILITIES; DISEASE-FREE SURVIVAL; EPENDYMOMA; ETOPOSIDE; FOLLOW-UP STUDIES; GANGLIOGLIOMA; GLIOMA; HUMANS; INFANT; MEDULLOBLASTOMA; MITOTIC INDEX; NEUROECTODERMAL TUMORS, PRIMITIVE; OLIGODENDROGLIOMA; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; QUADRIPLEGIA; RETROSPECTIVE STUDIES; SENSATION DISORDERS; SPINAL CORD NEOPLASMS; THIOTEPA; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME; VINCRISTINE;

EID: 33846904079     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.20781     Document Type: Article

References (16)

1. Duffner P, Horowitz M. Postoperative chemotherapy and delayed radiation in children less than three years of age with malignant brain tumors. N Engl J Med 1993;328:1725-1731.
2. Marec-Berard P, Jouvet A, Thiesse P, et al. Supratentorial embryonal tumors in children under 5 years of age: An SFOP study of treatment with postoperative chemotherapy alone. Med Pediatr Oncol 2002;38:83-90.
3. Gardner SL. Application of stem cell transplant for brain tumors. Pediatr Transplant 2004;8:28-32.
4. Finlay JL. The role of high-dose chemotherapy and stem cell rescue in the treatment of malignant brain tumors: A reappraisal. Pediatr Transplant 1999;3:87-95.
5. Wolff JE, Finlay JL. High-dose chemotherapy in childhood brain tumors. Onkologie 2004;27:239-245.
6. Dunkel IJ, Finlay JL. High-dose chemotherapy with autologous stem cell rescue for brain tumors. Crit Rev Oncol Hematol 2002;41:197-204.
7. Dupuis-Girod S, Hartmann O, Benhamou E, et al. Will high dose chemotherapy followed by autologous bone marrow transplantation supplant cranio-spinal irradiation in young children treated for medulloblastoma? J Neurooncol 1996;27:87-98.
8. Guruangan S, Dunkel IJ, Goldman S, et al. Myeloablative chemotherapy with autotogous bone marrow rescue in young children with recurrent malignant brain tumors. J Clin Oncol 1998;16:2486-2493.
9. Mason WP, Grovas A, Halpern S, et al. Intensive chemotherapy and bone marrow rescue for young children with newly diagnosed malignant brain tumors. J Clin Oncol 1998;16:210-221.
10. Perez-Martinez A, Quintero V, Vicent MG, et al. High dose chemotherapy with autologous stem cell rescue as first line treatment in young children with medulloblastoma and supratentorial primitive neuroectodermal tumors. J Neurooncol 2004;67: 101-106.
11. Broniscer A, Nicolaides TP, Dunkel IJ, et al. High dose chemotherapy with autologous stem-cell rescue in the treatment of patients with recurrent non-cerebellar primitive neuroectodermal tumors. Pediatr Blood Cancer 2004;42:261-267.
12. Perez-Martinez A, Quintero CV, Gonzalez VM, et al. High-dose chemotherapy with autologous stem cell rescue in children with high-risk and recurrent brain tumors. Ann Pediatr (Barc) 2004;61:8-15.
13. Fagioli F, Biasin E, Mastrodicasa L, et al. High-dose thiotepa and etoposide in children with poor-prognosis brain tumors. Cancer 2004;100:2215-2221.
14. Chi SN, Gardner SL, Levy AS, et al. Feasibility and response to induction chemotherapy intensified with high-dose methotrexate for young children with newly diagnosed high-risk disseminated medulloblastoma. J Clin Oncol 2004;22:4881-4887.
15. Sands SA, van Gorp WG, Finlay JL. Pilot neuropsychological findings from a treatment regimen consisting of intensive chemotherapy and bone marrow rescue for young children with newly diagnosed malignant brain tumors. Childs Nerv Syst 1998;14:587-589.
16. Freilich RJ, Kraus DH, Budnick AS, et al. Hearing loss in children with brain tumors treated with cisplatin and carboplatin-based high-dose chemotherapy with autologous bone marrow rescue. Med Pediatr Oncol 1996;26:95-100.